Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A new cognitive evaluation battery for Down syndrome and its relevance for clinical trials.
de Sola S, de la Torre R, Sánchez-Benavides G, Benejam B, Cuenca-Royo A, Del Hoyo L, Rodríguez J, Catuara-Solarz S, Sanchez-Gutierrez J, Dueñas-Espin I, Hernandez G, Peña-Casanova J, Langohr K, Videla S, Blehaut H, Farre M, Dierssen M; TESDAD Study Group. de Sola S, et al. Front Psychol. 2015 Jun 4;6:708. doi: 10.3389/fpsyg.2015.00708. eCollection 2015. Front Psychol. 2015. PMID: 26089807 Free PMC article.
Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down's syndrome (TESDAD): a double-blind, randomised, placebo-controlled, phase 2 trial.
de la Torre R, de Sola S, Hernandez G, Farré M, Pujol J, Rodriguez J, Espadaler JM, Langohr K, Cuenca-Royo A, Principe A, Xicota L, Janel N, Catuara-Solarz S, Sanchez-Benavides G, Bléhaut H, Dueñas-Espín I, Del Hoyo L, Benejam B, Blanco-Hinojo L, Videla S, Fitó M, Delabar JM, Dierssen M; TESDAD study group. de la Torre R, et al. Lancet Neurol. 2016 Jul;15(8):801-810. doi: 10.1016/S1474-4422(16)30034-5. Lancet Neurol. 2016. PMID: 27302362 Clinical Trial.
Cannabis Users Show Enhanced Expression of CB1-5HT2A Receptor Heteromers in Olfactory Neuroepithelium Cells.
Galindo L, Moreno E, López-Armenta F, Guinart D, Cuenca-Royo A, Izquierdo-Serra M, Xicota L, Fernandez C, Menoyo E, Fernández-Fernández JM, Benítez-King G, Canela EI, Casadó V, Pérez V, de la Torre R, Robledo P. Galindo L, et al. Mol Neurobiol. 2018 Aug;55(8):6347-6361. doi: 10.1007/s12035-017-0833-7. Epub 2018 Jan 2. Mol Neurobiol. 2018. PMID: 29294249
Type 2 diabetes and cognitive impairment in an older population with overweight or obesity and metabolic syndrome: baseline cross-sectional analysis of the PREDIMED-plus study.
Mallorquí-Bagué N, Lozano-Madrid M, Toledo E, Corella D, Salas-Salvadó J, Cuenca-Royo A, Vioque J, Romaguera D, Martínez JA, Wärnberg J, López-Miranda J, Estruch R, Bueno-Cavanillas A, Alonso-Gómez Á, Tur JA, Tinahones FJ, Serra-Majem L, Martín V, Lapetra J, Vázquez C, Pintó X, Vidal J, Daimiel L, Gaforio JJ, Matía P, Ros E, Granero R, Buil-Cosiales P, Barragán R, Bulló M, Castañer O, García-de-la-Hera M, Yáñez AM, Abete I, García-Ríos A, Ruiz-Canela M, Díaz-López A, Jiménez-Murcia S, Martínez-González MA, De la Torre R, Fernández-Aranda F. Mallorquí-Bagué N, et al. Sci Rep. 2018 Oct 31;8(1):16128. doi: 10.1038/s41598-018-33843-8. Sci Rep. 2018. PMID: 30382190 Free PMC article. Clinical Trial.
A phase 1, randomized double-blind, placebo controlled trial to evaluate safety and efficacy of epigallocatechin-3-gallate and cognitive training in adults with Fragile X syndrome.
de la Torre R, de Sola S, Farré M, Xicota L, Cuenca-Royo A, Rodriguez J, León A, Langohr K, Gomis-González M, Hernandez G, Esteba S, Del Hoyo L, Sánchez-Gutiérrez J, Cortés MJ, Ozaita A, Espadaler JM, Novell R, Martínez-Leal R, Milá M, Dierssen M; TESXF Study Group. de la Torre R, et al. Clin Nutr. 2020 Feb;39(2):378-387. doi: 10.1016/j.clnu.2019.02.028. Epub 2019 Mar 25. Clin Nutr. 2020. PMID: 30962103 Clinical Trial.
Physical fitness and physical activity association with cognitive function and quality of life: baseline cross-sectional analysis of the PREDIMED-Plus trial.
Daimiel L, Martínez-González MA, Corella D, Salas-Salvadó J, Schröder H, Vioque J, Romaguera D, Martínez JA, Wärnberg J, Lopez-Miranda J, Estruch R, Cano-Ibáñez N, Alonso-Gómez A, Tur JA, Tinahones FJ, Serra-Majem L, Micó-Pérez RM, Lapetra J, Galdón A, Pintó X, Vidal J, Micó V, Colmenarejo G, Gaforio JJ, Matía P, Ros E, Buil-Cosiales P, Vázquez-Ruiz Z, Sorlí JV, Graniel IP, Cuenca-Royo A, Gisbert-Sellés C, Galmes-Panades AM, Zulet MA, García-Ríos A, Díaz-López A, de la Torre R, Galilea-Zabalza I, Ordovás JM. Daimiel L, et al. Sci Rep. 2020 Feb 26;10(1):3472. doi: 10.1038/s41598-020-59458-6. Sci Rep. 2020. PMID: 32103064 Free PMC article. Clinical Trial.
Prefrontal Cortex Neuromodulation Enhances Frontal Asymmetry and Reduces Caloric Intake in Patients with Morbid Obesity.
Forcano L, Castellano M, Cuenca-Royo A, Goday-Arno A, Pastor A, Langohr K, Castañer O, Pérez-Vega KA, Serra C, Ruffini G, Alonso-Alonso M, Soria-Frisch A, de la Torre R. Forcano L, et al. Obesity (Silver Spring). 2020 Apr;28(4):696-705. doi: 10.1002/oby.22745. Epub 2020 Mar 6. Obesity (Silver Spring). 2020. PMID: 32144883 Clinical Trial.
Altered Signaling in CB1R-5-HT2AR Heteromers in Olfactory Neuroepithelium Cells of Schizophrenia Patients is Modulated by Cannabis Use.
Guinart D, Moreno E, Galindo L, Cuenca-Royo A, Barrera-Conde M, Pérez EJ, Fernández-Avilés C, Correll CU, Canela EI, Casadó V, Cordomi A, Pardo L, de la Torre R, Pérez V, Robledo P. Guinart D, et al. Schizophr Bull. 2020 Dec 1;46(6):1547-1557. doi: 10.1093/schbul/sbaa038. Schizophr Bull. 2020. PMID: 32249318 Free PMC article.
32 results